Cameron R. Nelson
Director of Finance/CFO at Mati Therapeutics, Inc.
Cameron R. Nelson active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Director of Finance/CFO | - | - |
Career history of Cameron R. Nelson
Former positions of Cameron R. Nelson
| Companies | Position | Start | End |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 24/05/2010 | 30/11/2011 |
| Director of Finance/CFO | 01/05/2000 | 09/07/2012 |
Training of Cameron R. Nelson
| Dartmouth College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Statistics
International
| Canada | 3 |
| United States | 3 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Health Technology |
- Stock Market
- Insiders
- Cameron R. Nelson
- Experience
